We have congregated information concerning stocks with the highest payout ratio up to now. The payout ratio in itself isn't a assurance of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. CrossAmerica Partners LP
76.09% Payout Ratio
CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States.
As maintained by Morningstar, Inc., the next dividend payment is on Nov 1, 2020, the estimated forward annual dividend rate is 2.1 and the estimated forward annual dividend yield is 12.38%.
CrossAmerica Partners LP's sales growth this year is expected to be negative 5.5% and 35.3% for next year.
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1.78B for the twelve trailing months.
CrossAmerica Partners LP's sales growth is 26.7% for the present present quarter and 61.8% for the next. The company's growth estimates for the ongoing quarter and the next is 8.3% and negative -93.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 97%.
CrossAmerica Partners LP's Stock Yearly Top and Bottom Value
CrossAmerica Partners LP's stock is valued at $17.30 at 01:23 EST, way below its 52-week high of $19.79 and way above its 52-week low of $6.81.
CrossAmerica Partners LP's Moving Average
CrossAmerica Partners LP's value is above its 50-day moving average of $15.95 and way higher than its 200-day moving average of $15.18.2. Huntington Bancshares Incorporated
84.51% Payout Ratio
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
As stated by Morningstar, Inc., the next dividend payment is on Dec 16, 2020, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 4.64%.
Huntington Bancshares Incorporated's sales growth this year is expected to be 5.6% and 1% for next year.
Year-on-year quarterly revenue growth declined by 3.2%, now sitting on 3.72B for the twelve trailing months.
Huntington Bancshares Incorporated's sales growth is 8.4% for the ongoing present quarter and 6.1% for the next. The company's growth estimates for the ongoing quarter and the next is 3.6% and 833.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.59%.
Huntington Bancshares Incorporated's Stock Yearly Top and Bottom Value
Huntington Bancshares Incorporated's stock is valued at $12.93 at 01:23 EST, way under its 52-week high of $15.60 and way above its 52-week low of $6.82.
Huntington Bancshares Incorporated's Moving Average
Huntington Bancshares Incorporated's value is higher than its 50-day moving average of $11.77 and way higher than its 200-day moving average of $10.06.Previous days news about Huntington Bancshares Incorporated
Huntington bancshares and TCF financial corporation announce merger to create top 10 U.S. regional bank. According to Business Insider on Mon Dec 14, "Copies of the joint proxy statement/prospectus and the filings with the SEC that will be incorporated by reference in the joint proxy statement/prospectus can also be obtained, without charge, by directing a request to Huntington Investor Relations, Huntington Bancshares Incorporated, Huntington Center, HC0935, 41 South High Street, Columbus, Ohio 43287, (800) 576-5007 or to TCF Investor Relations, TCF Financial Corporation, 333 W. Fort Street, Suite 1800, Detroit, Michigan 48226, (866) 258-1807.", "COLUMBUS, Ohio and DETROIT, Dec. 13, 2020 /PRNewswire/ --Huntington Bancshares Incorporated ("Huntington") (Nasdaq: HBAN; www.huntington.com), the parent company of The Huntington National Bank, and TCF Financial Corporation ("TCF") (Nasdaq: TCF; www.tcfbank.com), the parent company of TCF National Bank, today announced the signing of a definitive agreement under which the companies will combine in an all-stock merger with a total market value of approximately $22 billion to create a top 10 U.S. regional bank with dual headquarters in Detroit, Michigan and Columbus, Ohio."
3. GAMCO Natural Resources, Gold & Income Trust
483.33% Payout Ratio
GAMCO Natural Resources, Gold & Income Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC.
As claimed by Morningstar, Inc., the next dividend payment is on Dec 9, 2020, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 6.96%.
GAMCO Natural Resources, Gold & Income Trust's sales growth this year is expected to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on N/A for the twelve trailing months.
GAMCO Natural Resources, Gold & Income Trust's Stock Yearly Top and Bottom Value
GAMCO Natural Resources, Gold & Income Trust's stock is valued at $5.14 at 01:23 EST, way under its 52-week high of $6.19 and way above its 52-week low of $2.28.
GAMCO Natural Resources, Gold & Income Trust's Moving Average
GAMCO Natural Resources, Gold & Income Trust's worth is above its 50-day moving average of $4.95 and above its 200-day moving average of $4.96.4. Novartis
99.91% Payout Ratio
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.
According to Morningstar, Inc., the next dividend payment is on Mar 2, 2020, the estimated forward annual dividend rate is 3.09 and the estimated forward annual dividend yield is 3.39%.
Novartis's sales growth this year is expected to be 3.6% and 6.2% for next year.
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 49.58B for the twelve trailing months.
Novartis's sales growth is 3.9% for the present current quarter and 6.3% for the next. The company's growth estimates for the current quarter and the next is 2.3% and 1.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.25%.
Novartis's Stock Yearly Top and Bottom Value
Novartis's stock is valued at $91.98 at 01:23 EST, under its 52-week high of $99.84 and way higher than its 52-week low of $69.18.
Novartis's Moving Average
Novartis's value is higher than its 50-day moving average of $87.06 and higher than its 200-day moving average of $86.79.Previous days news about Novartis
Novartis : FDA panel recommends entresto to treat patients with hfpef. According to Business Insider on Wed Dec 16, "Novartis (NVS) said Tuesday that the US Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee voted 12 to 1 that the data presented support the use of Entresto in treatment of patients with heart failure with preserved ejection fraction or HfpEF."
Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to CNBC on Wed Dec 16, "Novartis (NVS) - Novartis received a Food and Drug Administration panel endorsement to expand use of its heart failure drug Entresto, currently approved for patients whose heart muscles do not contract effectively. ", "Novartis shares were up 1% in the premarket."
Novartis to buy cadent therapeutics for up to $770 million. According to Bloomberg Quint on Thu Dec 17, "Novartis AG agreed to buy Cadent Therapeutics, a U.S. developer of treatments for cognitive and mood disorders, for as much as $770 million, amid a recent wave of acquisitions in the pharmaceutical industry.", "Novartis will pay $210 million up front and privately owned Cadent will be eligible for payments of as much as $560 million upon meeting certain milestones, the Cambridge, Massachusetts-based company said Thursday."